References in periodicals archive ?
Regulatory and ethical issues involving cell therapy are important and are discussed.
The global stem cell therapy products market is expected to grow at a CAGR of 17.
The company has also generated pre-clinical efficacy data with its ReN005 stem cell therapy for Huntington's disease, a rare, genetic and fatal neurodegenerative disorder which affects around 1 in 100,000 people.
Further, the company will comprehensively support clinical trials of immune cell therapy conducted at the 22nd Century Medical Center.
parents continue to turn to cell therapy, despite the difficulties in getting the treatment, which is not licensed by the Food and Drug Administration.
Martinez-Rivera will conduct regenerative medicine workshops through the Stem Cell Therapy Network (http://www.
Worldwide stem cell therapy market is poised to grow at a CAGR of 39.
The goal of this report is to review the market for cell therapy products using screening reagents and instruments for analysis of individual components in tissue samples, blood, serum or plasma.
Reasons to Buy the Report: From an insight perspective, this research report focuses on various levels of analysis-industry analysis (pipeline analysis and investor's network), regulatory scenario, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high growth segments of the stem cell therapy market, high-growth regions and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.
Research in cell therapy is transforming the future of medicine.
com/research/pcgfhj/cell_therapy) has announced the addition of a new report "Global Cell Therapy - Technologies, Markets and Companies" to their offering.